BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1456089)

  • 21. Bone densitometry of excised vertebrae; anatomical relationships.
    Mazess RB; Pedersen P; Vetter J; Barden HS
    Calcif Tissue Int; 1991 Jun; 48(6):380-6. PubMed ID: 2070272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.
    Feber J; Gaboury I; Ni A; Alos N; Arora S; Bell L; Blydt-Hansen T; Clarson C; Filler G; Hay J; Hebert D; Lentle B; Matzinger M; Midgley J; Moher D; Pinsk M; Rauch F; Rodd C; Shenouda N; Siminoski K; Ward LM;
    Osteoporos Int; 2012 Feb; 23(2):751-60. PubMed ID: 21494860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis.
    Mellibovsky L; Prieto-Alhambra D; Mellibovsky F; Güerri-Fernández R; Nogués X; Randall C; Hansma PK; Díez-Perez A
    J Bone Miner Res; 2015 Sep; 30(9):1651-6. PubMed ID: 25736591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients.
    Shuai B; Yang YP; Shen L; Zhu R; Xu XJ; Ma C; Lv L; Zhao J; Rong JH
    Osteoporos Int; 2015 Mar; 26(3):1063-71. PubMed ID: 25516362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children.
    Hansen KE; Kleker B; Safdar N; Bartels CM
    Semin Arthritis Rheum; 2014 Aug; 44(1):47-54. PubMed ID: 24680381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of bone densitometry studies.
    Blake GM; Fogelman I
    Semin Nucl Med; 1997 Jul; 27(3):248-60. PubMed ID: 9224665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid.
    Chikada N; Imaki T; Hotta M; Sato K; Takano K
    Endocr J; 2004 Jun; 51(3):355-60. PubMed ID: 15256782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A marked increase in bone mineral density in a patient with glucocorticoid-induced osteoporosis.
    Audran M; Audran-Avenel M; Simon Y; Legrand E
    J Clin Densitom; 1999; 2(4):453-5. PubMed ID: 10677798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Densitometric analysis of the human calcaneus.
    Fernandez Camacho FJ; Morante Martinez P; Rodríguez Torres R; Cortes García A; Gomez Pellico L
    J Anat; 1996 Aug; 189 ( Pt 1)(Pt 1):205-9. PubMed ID: 8771413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in DPX densitometry].
    Vojtassák J
    Bratisl Lek Listy; 1997 Feb; 98(2):118-22. PubMed ID: 9264810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a key gene module associated with glucocorticoid- induced derangement in bone mineral density in patients with asthma.
    Lee SY; Won HK; Kim BK; Kim SH; Chang YS; Cho SH; Kelly HW; Tantisira KG; Park HW
    Sci Rep; 2019 Dec; 9(1):20133. PubMed ID: 31882850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the rate of bone loss: a technique revisited.
    Reeve J; Lunt M
    J Bone Miner Res; 1999 Nov; 14(11):1990-1. PubMed ID: 10571701
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteoporosis in rheumatological practice: questions to be answered.
    Cooper C
    Ann Rheum Dis; 1995 Jan; 54(1):1-2. PubMed ID: 7880114
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.
    Gluck OS; Murphy WA; Hahn TJ; Hahn B
    Arthritis Rheum; 1981 Jul; 24(7):892-8. PubMed ID: 7259801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpretation of bone densitometry measurements: disadvantages of a percentage scale and a discussion of some alternatives.
    Parfitt AM
    J Bone Miner Res; 1990 Jun; 5(6):537-40. PubMed ID: 2200238
    [No Abstract]   [Full Text] [Related]  

  • 36. Quoting intermediate analyses can only mislead.
    Bland JM
    BMJ; 1997 Jun; 314(7098):1907-8. PubMed ID: 9224157
    [No Abstract]   [Full Text] [Related]  

  • 37. Lateral spine dual-energy X-ray absorptiometry and the risk of fragility fractures in long-term kidney graft recipients.
    Hori M; Yasuda K; Takahashi H; Matsuoka Y; Tsujita M; Nishihira M; Uchida K; Morozumi K; Maruyama S
    Clin Exp Nephrol; 2022 Jul; 26(7):724-732. PubMed ID: 35304690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone microarchitecture and metabolism in elderly male patients with signs of intravertebral cleft on MRI.
    Qi H; Qi J; Sun Y; Gao J; Sun J; Wang G
    Eur Radiol; 2022 Jun; 32(6):3931-3943. PubMed ID: 34989849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractal properties and radiomorphometric indices of the trabecular structure of the mandible in patients using systemic glucocorticoids.
    Ersu N; Akyol R; Etöz M
    Oral Radiol; 2022 Apr; 38(2):252-260. PubMed ID: 34213705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.
    Choudhary S; Agarwal I; Seshadri MS
    Pediatr Nephrol; 2014 Jun; 29(6):1025-32. PubMed ID: 24414607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.